These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19879073)

  • 21. Associations of Hearing Loss and Menopausal Hormone Therapy With Change in Global Cognition and Incident Cognitive Impairment Among Postmenopausal Women.
    Armstrong NM; Espeland MA; Chen JC; Masaki K; Wactawski-Wende J; Li W; Gass MLS; Stefanick ML; Manson JE; Deal JA; Rapp SR; Lin FR; Resnick SM
    J Gerontol A Biol Sci Med Sci; 2020 Feb; 75(3):537-544. PubMed ID: 31326978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postmenopausal hormone treatment alters neural pathways but does not improve verbal cognitive function.
    Berent-Spillson A; Kelley AS; Persad CC; Love T; Frey KA; Reame NE; Koeppe R; Zubieta JK; Smith YR
    Menopause; 2018 Dec; 25(12):1424-1431. PubMed ID: 29994967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormone Therapy Use and Risk of Chronic Disease in the Nurses' Health Study: A Comparative Analysis With the Women's Health Initiative.
    Bhupathiraju SN; Grodstein F; Rosner BA; Stampfer MJ; Hu FB; Willett WC; Manson JE
    Am J Epidemiol; 2017 Sep; 186(6):696-708. PubMed ID: 28938710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Women's Health Initiative Memory Study: findings and implications for treatment.
    Craig MC; Maki PM; Murphy DG
    Lancet Neurol; 2005 Mar; 4(3):190-4. PubMed ID: 15721829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
    Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
    J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
    Harman SM; Naftolin F; Brinton EA; Judelson DR
    Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H; Stevenson J
    Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long term hormone therapy for perimenopausal and postmenopausal women.
    Marjoribanks J; Farquhar C; Roberts H; Lethaby A
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.
    Smith NL; Heckbert SR; Lemaitre RN; Reiner AP; Lumley T; Weiss NS; Larson EB; Rosendaal FR; Psaty BM
    JAMA; 2004 Oct; 292(13):1581-7. PubMed ID: 15467060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms underlying social inequality in post-menopausal breast cancer.
    Hvidtfeldt UA
    Dan Med J; 2014 Oct; 61(10):B4922. PubMed ID: 25283627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials.
    Manson JE; Aragaki AK; Rossouw JE; Anderson GL; Prentice RL; LaCroix AZ; Chlebowski RT; Howard BV; Thomson CA; Margolis KL; Lewis CE; Stefanick ML; Jackson RD; Johnson KC; Martin LW; Shumaker SA; Espeland MA; Wactawski-Wende J;
    JAMA; 2017 Sep; 318(10):927-938. PubMed ID: 28898378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.
    Anderson GL; Limacher M; Assaf AR; Bassford T; Beresford SA; Black H; Bonds D; Brunner R; Brzyski R; Caan B; Chlebowski R; Curb D; Gass M; Hays J; Heiss G; Hendrix S; Howard BV; Hsia J; Hubbell A; Jackson R; Johnson KC; Judd H; Kotchen JM; Kuller L; LaCroix AZ; Lane D; Langer RD; Lasser N; Lewis CE; Manson J; Margolis K; Ockene J; O'Sullivan MJ; Phillips L; Prentice RL; Ritenbaugh C; Robbins J; Rossouw JE; Sarto G; Stefanick ML; Van Horn L; Wactawski-Wende J; Wallace R; Wassertheil-Smoller S;
    JAMA; 2004 Apr; 291(14):1701-12. PubMed ID: 15082697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alzheimer's disease, menopause and the impact of the estrogenic environment.
    Pines A
    Climacteric; 2016 Oct; 19(5):430-2. PubMed ID: 27327261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen metabolism in menopausal hormone users in the women's health initiative observational study: Does it differ between estrogen plus progestin and estrogen alone?
    Falk RT; Manson JE; Barnabei VM; Anderson GL; Brinton LA; Rohan TE; Cauley JA; Chen C; Coburn SB; Pfeiffer RM; Reding KW; Sarto GE; Wentzensen N; Chlebowski RT; Xu X; Trabert B
    Int J Cancer; 2019 Feb; 144(4):730-740. PubMed ID: 30183089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of cardiovascular disease in relation to the use of combined postmenopausal hormone therapy: detection bias and resolution of discrepant findings in two Women's Health Initiative studies.
    Shapiro S
    Climacteric; 2006 Dec; 9(6):416-20. PubMed ID: 17085373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
    Rossouw JE; Anderson GL; Prentice RL; LaCroix AZ; Kooperberg C; Stefanick ML; Jackson RD; Beresford SA; Howard BV; Johnson KC; Kotchen JM; Ockene J;
    JAMA; 2002 Jul; 288(3):321-33. PubMed ID: 12117397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
    Modena MG; Sismondi P; Mueck AO; Kuttenn F; Lignières Bd; Verhaeghe J; Foidart JM; Caufriez A; Genazzani AR;
    Maturitas; 2005 Sep; 52(1):1-10. PubMed ID: 15963666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postmenopausal hormone replacement therapy: scientific review.
    Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
    JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy.
    Roach RE; Lijfering WM; Helmerhorst FM; Cannegieter SC; Rosendaal FR; van Hylckama Vlieg A
    J Thromb Haemost; 2013 Jan; 11(1):124-31. PubMed ID: 23136837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen-alone therapy and invasive breast cancer incidence by dose, formulation, and route of delivery: findings from the WHI observational study.
    Shufelt C; Bairey Merz CN; Pettinger MB; Choi L; Chlebowski R; Crandall CJ; Liu S; Lane D; Prentice R; Manson JE;
    Menopause; 2018 Sep; 25(9):985-991. PubMed ID: 29738414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.